Fig. 3From: Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxisUnivariate and multivariate cox analyses of progression-free survial (PFS) stratified by baseline characteristicsBack to article page